CIK: 0001664974 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value ($000): $105,690 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EVLV | Evolv Technologies Holdings, Inc. | 9,681,280 | $47,051 | 44.5% | $5.61 | +9.8% | COM CL A | 30049H102 |
| RXRX | Recursion Pharmaceuticals, Inc. | 5,941,120 | $45,450 | 43.0% | $18.82 | -47.0% | CL A | 75629V104 |
| — | Rocket Lab USA, Inc. | 2,929,350 | $12,831 | 12.1% | $4.04 | — | COM | 773122106 |
| — | Mind Medicine (MindMed) Inc. | 100,349 | $314 | 0.3% | $3.17 | — | COM NEW | 60255C885 |
| ROIV | Roivant Sciences Ltd. | 3,875 | $45 | 0.0% | $5.56 | +103.2% | SHS | G76279101 |